Anderson J A, Chen C C, Vita J B, Shackleton M
Arch Ophthalmol. 1982 Apr;100(4):642-5. doi: 10.1001/archopht.1982.01030030644024.
In a study of the ocular absorption and elimination of a topically applied non-steroidal anti-inflammatory drug (NSAID), flurbiprofen, the compound was well absorbed into rabbit ocular tissues and was highly concentrated in the rabbit cornea. In aphakic eyes, more drug penetrated to the vitreous and choroid-retina area than in normal rabbit eyes, although corneal concentrations were still high. No ocular metabolism of flurbiprofen could be detected, and the ocular route of application did not lead to any changes in blood elimination rates or metabolism when compared with intravenously injected drug. Currently, no NSAID is available for topical ocular use, and the development of such a drug is desirable for treatment of ocular inflammations, especially when long-term treatment is indicated.
在一项关于局部应用非甾体抗炎药(NSAID)氟比洛芬的眼部吸收与消除的研究中,该化合物能很好地被兔眼组织吸收,并在兔角膜中高度浓缩。在无晶状体眼中,尽管角膜浓度仍然很高,但与正常兔眼相比,更多的药物渗透到玻璃体和脉络膜 - 视网膜区域。未检测到氟比洛芬的眼部代谢,并且与静脉注射药物相比,眼部给药途径未导致血液消除率或代谢发生任何变化。目前,尚无NSAID可用于局部眼部用药,开发这样一种药物对于眼部炎症的治疗是可取的,尤其是在需要长期治疗时。